Buys
Open market- Shares
- Avg price
- Total value
Muthusamy Shanmugam - HEAD OF R&D, COO-NOVITIUM OPS, Director at ANI PHARMACEUTICALS INC
Insider Transactions and Holdings
- Entity type
- Individual
- Role
- HEAD OF R&D, COO-NOVITIUM OPS, Director
- Issuer symbol
- ANIP on Nasdaq
- Source filings
- Open source filing history
Identity
Issuer context
SEC evidence
Muthusamy Shanmugam - trading volume in the past year for ANI PHARMACEUTICALS INC
Sells
Open market- Shares
- -200,000
- Avg price
- $89.30
- Total value
- -$17,860,541
Net
Past year- Shares
- -200,000
- Share %
- -100%
- Total value
- -$17,860,541
Holdings reported by Muthusamy Shanmugam for ANI PHARMACEUTICALS INC
Form 4 holding
HEAD OF R&D, COO-NOVITIUM OPS, Director
ANI PHARMACEUTICALS INC
- Security class
- Common Stock
- Shares / value
- 431,920
- Estimated value
- $36,432,452
- Report date
- 26 Feb 2026
- Price
- $84.35
- Ownership
- Held by Esjay LLC
Form 4 holding
HEAD OF R&D, COO-NOVITIUM OPS, Director
ANI PHARMACEUTICALS INC
- Security class
- Common Stock
- Shares / value
- 101,056
- Estimated value
- $7,796,470
- Report date
- 26 Feb 2026
- Price
- $77.15
- Ownership
- Direct
Form 4 holding
HEAD OF R&D, COO-NOVITIUM OPS, Director
ANI PHARMACEUTICALS INC
- Security class
- Common Stock
- Shares / value
- 5,000
- Estimated value
- $421,750
- Report date
- 26 Feb 2026
- Price
- $84.35
- Ownership
- Held by SS Pharma LLC
Transactions reported by Muthusamy Shanmugam for ANI PHARMACEUTICALS INC
| Sym | Class | Transaction | % | Reported value | Reported price | Shares | Shares after | Date | Ownership |
|---|
* indicates a reported price that failed the local validity check.